Elevian Company

Elevian’s founders discovered circulating blood factors that regulate aging, including GDF11, which broadly stimulate regeneration of brain, heart, pancreas, muscle, and other tissues. Elevian is developing therapeutics that stimulate regenerative capacity, to treat and prevent age-related disease.
Technology: Regenerative Medicine
Industry: Biopharma, Biotechnology
Headquarters: Allston, Massachusetts, United States
Founded Date: 2017-07-15
Employees Number: 1-10
Funding Status: Seed
Investors Number: 4
Total Funding: $9.3M
Estimated Revenue: Less than $1M
Last Funding Type: Seed

Visit Website
info@elevian.com
Register and Claim Ownership